Palatin Technologies, Inc
11 clinical trials · Sponsor
◉ Watch Palatin Technologies, Inc
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity (NCT06565611) | Palatin Technologies, Inc | 2024-08-05 |
| A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease (NCT05709444) | Palatin Technologies, Inc | 2022-12-26 |
| A Phase 3, Multi-Center Study Evaluating PL9643 in Patients with Dry Eye (NCT05201170) | Palatin Technologies, Inc | 2021-12-30 |
| Study to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure Subjects (NCT04318145) | Palatin Technologies, Inc | 2020-11-12 |
Track Palatin Technologies, Inc automatically
Every clearance here is in the API, with alerts when new ones post.